GET THE APP

Antibiotic Stewardship in the Age of Antimicrobial Resistance: Innovations and Challenges
..

Journal of Infectious Diseases and Medicine

ISSN: 2576-1420

Open Access

Mini Review - (2023) Volume 8, Issue 4

Antibiotic Stewardship in the Age of Antimicrobial Resistance: Innovations and Challenges

Rianka Haenen*
*Correspondence: Rianka Haenen, Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy, Email:
Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy

Received: 01-Aug-2023, Manuscript No. jidm-23-114054; Editor assigned: 03-Aug-2023, Pre QC No. P-114054; Reviewed: 17-Aug-2023, QC No. Q-114054; Revised: 23-Aug-2023, Manuscript No. R-114054; Published: 31-Aug-2023 , DOI: 10.37421/2576-1420.2023.8.302
Citation: Haenen, Rianka. “Antibiotic Stewardship in the Age of Antimicrobial Resistance: Innovations and Challenges.” J Infect Dis Med 8 (2023): 302.
Copyright: © 2023 Haenen R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

The emergence of Antimicrobial Resistance (AMR) poses a critical threat to global public health. Antibiotic stewardship programs have become essential tools in combating this growing crisis. This article explores the innovations and challenges associated with antibiotic stewardship in the context of AMR. It delves into the latest advancements in stewardship strategies, the role of technology, and the socio-economic factors influencing antibiotic use. By critically examining these aspects, we aim to provide insights that will guide efforts to optimize antibiotic use, preserve these life-saving drugs, and mitigate the consequences of AMR.

Keywords

Antibiotic stewardship • Antimicrobial resistance • AMR • Innovation • Challenges • Antibiotic use • healthcare • Public health

Introduction

The rise of Antimicrobial Resistance (AMR) has emerged as a formidable global health challenge, threatening the effectiveness of antibiotics and other antimicrobial agents. Antibiotic stewardship, which entails the responsible and judicious use of antibiotics, has become a pivotal strategy in mitigating the spread of AMR. This article delves into the innovations and challenges associated with antibiotic stewardship, offering a comprehensive perspective on the efforts to address AMR in an increasingly complex healthcare landscape [1].

Literature Review

This section explores the latest innovations in antibiotic stewardship programs. We examine how healthcare institutions and professionals are adopting new strategies to optimize antibiotic use, including the development of clinical guidelines, implementation of antibiotic stewardship teams, and the use of electronic health records to track and manage antibiotic prescriptions [2,3]. The article delves into the technological innovations that have the potential to transform antibiotic stewardship. This includes the use of artificial intelligence and machine learning to assist in diagnostic decision-making and the development of rapid diagnostic tests that can identify pathogens and their susceptibility to antibiotics in real-time. We also consider the socio-economic factors that influence antibiotic use, including patient expectations, cultural beliefs, and healthcare system structures. Understanding these influences is critical for tailoring stewardship interventions that are effective and culturally sensitive [4,5].

Discussion

In the discussion section, we synthesize the insights from the preceding sections, emphasizing the dynamic nature of antibiotic stewardship in the face of AMR. We discuss the challenges that healthcare providers and systems encounter in implementing stewardship programs, including resource constraints and the need for ongoing education and training. Additionally, we highlight the importance of a global perspective in addressing AMR, as antibiotic resistance knows no borders [6].

Conclusion

In conclusion, antibiotic stewardship is a vital component of the multifaceted strategy required to combat antimicrobial resistance effectively. This article has examined both the innovations and challenges associated with stewardship efforts, emphasizing the need for continued innovation and adaptation in response to the evolving landscape of AMR. By optimizing antibiotic use, harnessing technology, and addressing socio-economic influences, we can work towards preserving these life-saving drugs and mitigating the consequences of AMR for the well-being of present and future generations. Effective antibiotic stewardship is not only a healthcare imperative but a global responsibility to safeguard public health.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Vaz-Moreira, Ivone, Olga C. Nunes and Célia M. Manaia. "Bacterial diversity and antibiotic resistance in water habitats: Searching the links with the human microbiome." FEMS Microbiol Rev 38 (2014): 761-778.
  2. Google Scholar, Crossref, Indexed at

  3. Barbosa-Vasconcelos, Ana, Ângelo Mendes, Flávia Martins and Lucinda J. Bessa, et al. "River water analysis using a multiparametric approach: Portuguese river as a case study." J Water Health 16 (2018): 991-1006.
  4. Google Scholar, Crossref, Indexed at

  5. Ferreira da Silva, Miguel, Ivone Vaz-Moreira, Maria Gonzalez-Pajuelo and Celia M. Manaia, et al. "Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban wastewater treatment plant." FEMS Microbiol Ecol 60 (2007): 166-176.
  6. Google Scholar, Crossref, Indexed at

  7. Kürekci, Cemil, Muhsin Aydin, Mustafa Yipel and Aycan Gündoğdu, et al. "Characterization of Extended Spectrum β-Lactamase (ESBL)-producing Escherichia coli in Asi (Orontes) River in Turkey." J Water Health 15 (2017): 788-798.
  8. Google Scholar, Crossref, Indexed at

  9. Han, Ning, Duohong Sheng and Hai Xu. "Role of Escherichia coli strain subgroups, integrons, and integron-associated gene cassettes in dissemination of antimicrobial resistance in aquatic environments of Jinan, China." Water Sci Technol 66 (2012): 2385-2392.
  10. Google Scholar, Crossref, Indexed at

  11. Maitra, Arundhati, Tulika Munshi, Jess Healy and Sanjib Bhakta, et al. "Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen." FEMS Microbiol Rev 43 (2019): 548-575.
  12. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 59

Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report

Journal of Infectious Diseases and Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward